L Xi1, Z Qian, G Xu, C Zhou, S Sun. 1. Department of Pharmacology, China Pharmaceutical University, Nanjing, PR China.
Abstract
BACKGROUND AND PURPOSE: A number of studies have implicated adipocyte-derived factors in the development of insulin resistance. Intracellular redox status has been reported to play a significant role in the modulation of insulin action. This study was designed to investigate the potential of crocetin, a potent antioxidant, to protect adipocytes against the induction of insulin insensitivity and disordered expression of tumor necrosis factor (TNF)-alpha and adiponectin in vitro. EXPERIMENTAL APPROACH: We used palmitate to induce insulin resistance in freshly isolated rat adipocytes, and observed the effect of crocetin, N-acetylcysteine, diphenyleneiodonium, rotenone and oxypurinol. Insulin sensitivity was measured using 2-deoxy-D-[1-(3)H]-glucose uptake assay. Levels of glucose transporter 4, TNF-alpha and adiponectin were evaluated by immunoblot analysis, and levels of mRNA for TNF-alpha and adiponectin by reverse transcription-polymerase chain reaction analysis. Intracellular production of reactive oxygen species (ROS) was determined spectrofluorometrically using 2',7'-dichlorofluorescin diacetate. KEY RESULTS: Palmitate induced a 45% decrease in insulin-stimulated glucose uptake in adipocytes. The mRNA and protein expression of TNF-alpha were enhanced by 64% and 59% respectively whereas the mRNA and protein expression of adiponectin were reduced by 43% and 36% respectively by palmitate treatment. These changes were accompanied by a 54% increase in intracellular ROS levels. Crocetin, N-acetylcysteine and diphenyleneiodonium were found to attenuate these abnormalities. CONCLUSIONS AND IMPLICATIONS: Crocetin blocked the impaired insulin-stimulated glucose uptake and disordered TNF-alpha and adiponectin expression induced by palmitate in rat adipocytes. Inactivation of NADPH oxidase may account for these observations.
BACKGROUND AND PURPOSE: A number of studies have implicated adipocyte-derived factors in the development of insulin resistance. Intracellular redox status has been reported to play a significant role in the modulation of insulin action. This study was designed to investigate the potential of crocetin, a potent antioxidant, to protect adipocytes against the induction of insulin insensitivity and disordered expression of tumor necrosis factor (TNF)-alpha and adiponectin in vitro. EXPERIMENTAL APPROACH: We used palmitate to induce insulin resistance in freshly isolated rat adipocytes, and observed the effect of crocetin, N-acetylcysteine, diphenyleneiodonium, rotenone and oxypurinol. Insulin sensitivity was measured using 2-deoxy-D-[1-(3)H]-glucose uptake assay. Levels of glucose transporter 4, TNF-alpha and adiponectin were evaluated by immunoblot analysis, and levels of mRNA for TNF-alpha and adiponectin by reverse transcription-polymerase chain reaction analysis. Intracellular production of reactive oxygen species (ROS) was determined spectrofluorometrically using 2',7'-dichlorofluorescin diacetate. KEY RESULTS:Palmitate induced a 45% decrease in insulin-stimulated glucose uptake in adipocytes. The mRNA and protein expression of TNF-alpha were enhanced by 64% and 59% respectively whereas the mRNA and protein expression of adiponectin were reduced by 43% and 36% respectively by palmitate treatment. These changes were accompanied by a 54% increase in intracellular ROS levels. Crocetin, N-acetylcysteine and diphenyleneiodonium were found to attenuate these abnormalities. CONCLUSIONS AND IMPLICATIONS: Crocetin blocked the impaired insulin-stimulated glucose uptake and disordered TNF-alpha and adiponectin expression induced by palmitate in rat adipocytes. Inactivation of NADPH oxidase may account for these observations.
Authors: T Inoguchi; P Li; F Umeda; H Y Yu; M Kakimoto; M Imamura; T Aoki; T Etoh; T Hashimoto; M Naruse; H Sano; H Utsumi; H Nawata Journal: Diabetes Date: 2000-11 Impact factor: 9.461
Authors: R N Cortright; J L Azevedo; Q Zhou; M Sinha; W J Pories; S I Itani; G L Dohm Journal: Am J Physiol Endocrinol Metab Date: 2000-03 Impact factor: 4.310
Authors: Agnieszka U Błachnio-Zabielska; Marcin Baranowski; Tomasz Hirnle; Piotr Zabielski; Anna Lewczuk; Iwona Dmitruk; Jan Górski Journal: Lipids Date: 2012-10-10 Impact factor: 1.880
Authors: Shakun Karki; Partha Chakrabarti; Guanrong Huang; Hong Wang; Stephen R Farmer; Konstantin V Kandror Journal: PLoS One Date: 2011-11-29 Impact factor: 3.240
Authors: María José Bagur; Gonzalo Luis Alonso Salinas; Antonia M Jiménez-Monreal; Soukaina Chaouqi; Silvia Llorens; Magdalena Martínez-Tomé; Gonzalo L Alonso Journal: Molecules Date: 2017-12-23 Impact factor: 4.411